Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis

被引：0
|
作者：
Kita, Kanako [1 ]
Imai, Yasutomo [1 ,2 ]
Nagai, Makoto [1 ]
Natsuaki, Masaru [1 ]
Kanazawa, Nobuo [1 ]
机构：
[1] Hyogo Med Univ, Dept Dermatol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
[2] Imai Adult & Pediat Dermatol, Osaka, Japan
来源：
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY | 2023年 / 6卷 / 03期
基金：
日本学术振兴会;
关键词：
D O I：
10.1002/cia2.12282
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Dupilumab treatment reduced serum SCCA2 levels in patients with atopic dermatitis. Interestingly, even though the skin eruptions had not yet fully disappeared, serum SCCA2 levels were reduced well to below normal by the administration of dupilumab.
引用
收藏
页码：100 / 101
页数：2
相关论文
共 50 条
  • [41] Dupilumab for treatment of atopic dermatitis in patients living with HIV: a case series
    Nusbaum, Kelsey B.
    Kaffenberger, Benjamin H.
    Paradiso, Michela M.
    Sopkovich, Jennifer A.
    Daou, Hala
    Seminario-Vidal, Lucia
    Trinidad, John C.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) : E344 - E346
  • [42] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Muraro, Antonella
    Boguniewicz, Mark
    Chen, Zhen
    Zahn, Joseph
    Marco, Ainara Rodriguez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01)
  • [43] A study of dupilumab in Chinese patients with atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E176 - E176
  • [44] Practical Management of Patients with Atopic Dermatitis on Dupilumab
    Papp, Kim A.
    Hong, Chih-ho
    Lansang, M. Perla
    Turchin, Irina
    Adam, David N.
    Beecker, Jennifer R.
    Bissonnette, Robert
    Gooderham, Melinda J.
    Jack, Carolyn
    Joseph, Marissa
    Lynde, Charles W.
    Shear, Neil H.
    DERMATOLOGY AND THERAPY, 2021, 11 (05) : 1805 - 1828
  • [45] Dupilumab in Elderly Patients With Severe Atopic Dermatitis
    Russo, Filomena
    Milanesi, Nicola
    Cartocci, Alessandra
    Bruzziches, Francesco
    Tronconi, Greta
    Lazzeri, Laura
    D'erme, Angelo Massimiliano
    Bagnoni, Giovanni
    Gola, Massimo
    Cinotti, Elisa
    Rubegni, Pietro
    Flori, Maria Laura
    DERMATITIS, 2021, 32 (1S) : S24 - S27
  • [46] Practical Management of Patients with Atopic Dermatitis on Dupilumab
    Kim A. Papp
    Chih-ho Hong
    M. Perla Lansang
    Irina Turchin
    David N. Adam
    Jennifer R. Beecker
    Robert Bissonnette
    Melinda J. Gooderham
    Carolyn Jack
    Marissa Joseph
    Charles W. Lynde
    Neil H. Shear
    Dermatology and Therapy, 2021, 11 : 1805 - 1828
  • [47] 5 Years of Dupilumab for Patients with atopic Dermatitis
    不详
    DERMATOLOGIE IN BERUF UND UMWELT, 2023, 71 (01) : 42 - 42
  • [48] The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
    Kamal, Mohamed A.
    Kovalenko, Pavel
    Kosloski, Matthew P.
    Srinivasan, Kamal
    Zhang, Yi
    Rajadhyaksha, Manoj
    Lai, Ching-Ha
    Kanamaluru, Vanaja
    Xu, Christine
    Sun, Xian
    Simpson, Eric L.
    Paller, Amy S.
    Siegfried, Elaine C.
    Shumel, Brad
    Bansal, Ashish
    Al-Huniti, Nidal
    Davis, John D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1318 - 1328
  • [49] The serum TSLP levels are not elevated in patients with atopic dermatitis
    Nakamura, K.
    Tsuchida, T.
    Tsunemi, Y.
    Saeki, H.
    Tamaki, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S169 - S169
  • [50] COMBINATION THERAPY OF DUPILUMAB AND BARICITINIB FOR THE TREATMENT OF ATOPIC DERMATITIS DUPILUMAB BARICITINIB
    Kook, Hyung Don
    Park, So Yun
    Hong, Narang
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Youn
    Ahn, Jiyoung
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 29 - 29
12345